HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guillaume Beaudoin-Bussières Selected Research

1- (3- (2- hydroxyl- 3- piperidin- 1- yl- propoxy)- phenoxy)- 3- piperidin- 1- ylpropan- 2- ol

7/2022VE607 stabilizes SARS-CoV-2 Spike in the "RBD-up" conformation and inhibits viral entry.
2/2022VE607 Stabilizes SARS-CoV-2 Spike In the "RBD-up" Conformation and Inhibits Viral Entry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guillaume Beaudoin-Bussières Research Topics

Disease

13COVID-19
07/2022 - 10/2020
6Infections
02/2022 - 07/2020
2Coinfection
01/2021 - 01/2021
2Convalescence
01/2021 - 01/2021
1Severe Acute Respiratory Syndrome
06/2021

Drug/Important Bio-Agent (IBA)

6Neutralizing AntibodiesIBA
01/2022 - 07/2020
6VaccinesIBA
01/2022 - 09/2020
4AntibodiesIBA
08/2021 - 09/2020
2Glycoproteins (Glycoprotein)IBA
07/2022 - 02/2022
21- (3- (2- hydroxyl- 3- piperidin- 1- yl- propoxy)- phenoxy)- 3- piperidin- 1- ylpropan- 2- olIBA
07/2022 - 02/2022
2Immunoglobulin M (IgM)IBA
06/2021 - 01/2021
2Immunoglobulin A (IgA)IBA
06/2021 - 01/2021
1Pharmaceutical PreparationsIBA
07/2022
1RNA (Ribonucleic Acid)IBA
11/2021
1Oxygen (Dioxygen)IBA
11/2021
1ImmunosorbentsIBA
06/2021
1Immunoglobulins (Immunoglobulin)IBA
06/2021
1EnzymesIBA
06/2021
1EpitopesIBA
09/2020

Therapy/Procedure

3Therapeutics
07/2022 - 01/2021
2Immunotherapy
07/2022 - 02/2022